News About: Pharm. Affairs


‘Viead’ cruises both in prescription and import

While ‘Viread(generic name: tenofovir), the Gilead’s hepatitis B therapy, outnumbered BMS’s ‘Baraclude’ and became the top in the ETC drug market, it continued a smooth flow as ...

Hanmi’s 4 products including ‘Amosartan 5/50mg’ manufactured worth of KRW 67.2 billion

The last year’s total manufactured amount of products which were approved as an incrementally modified drug was KRW 184.2 billion, and the Hanmi Pharm’s 4 products including ‘Am...

Cialis generics expect sales increase with prostate enlargement indication

With the original, Cialis generics will soon be available for the use of benign prostatic hyperplasia treatment. As the post-marketing surveillance on the Cialis 5mg’s positive benign prostatic hyperplasia indicatio...

“Legislation announcement about pharmaceutical dispensers contains so many problems”

The Korean Pharmaceutical Association(President Chan-hui Jo) held the Struggle Committee(Chairperson Nam-il Jung, Vice President of the pharmacy division) meeting to block the 3rd regulatory reform to the Pharmaceutic...

“Disused stocks create enormous damages," worth annual KRW 2 trillion

The pharmaceutical distribution industry rolled their sleeves for the ‘Legislation of Returning Disused Stocks.’ As the nations is damaged by disused stocks for trillions of wons, returning them must be legally force...

Creation of ‘olmesartan’ administration prohibition on chronic malabsorption patients

The antihypertensive olmesartan’s safety issue has been settled by newly creating a measure about prohibition of administration on chronic malabsorption syndrome patients in the approval article of olmesartan. On the...

Domestic companies challenge inhaler market being monopolized by foreign ones

A series of domestic pharmaceutical companies have given prior notices to enter the inhaler market whose product dependency is mostly high on multinational companies. Inhalers are usually launched by a small number o...

Rapid growth of quasi drug market, caused by MERS and fine dust

Since interests have been increased towards the health and hygiene field, such as MERS and fine dust, the quasi drug market has grown promptly. On the 22nd, the Ministry of Health and Welfare announced the 2015’s dom...

Corporate pharmacy and one pharmacist for multiple pharmacies will be decided this July

The development strategy of service economy, which has possibility to contain corporate pharmacy, extension of dispensing within medical institutes, multiple pharmacies for a single pharmacist, will be revealed early ...

Listed cosmetics companies’ sales exceed KRW 9 trillion last year

Last year, 18 listed cosmetics companies recorded KRW 9 trillion sales, and made KRW 1 trillion sales for the first time. According to the ‘2015 Export Condition of Healthcare Industry’ data published by the Ministry...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.